XML 87 R74.htm IDEA: XBRL DOCUMENT
v3.4.0.3

Note 14 - Operating Segment Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2016 | Dec. 31, 2015 | Sep. 30, 2015 | Jun. 30, 2015 | Mar. 31, 2015 | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2016 | Mar. 31, 2015 | Mar. 31, 2014
Biological Indicators [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  |  |  |  | $ 33,649 |  | $ 27,390 |  | $ 22,992
Gross profit |  |  |  |  |  |  |  |  |  |  |  |  | 22,205 |  | 17,142 |  | 13,187
Selling expenses |  |  |  |  |  |  |  |  |  |  |  |  | 1,734 |  | 1,551 |  | 1,350
Gross profit after deducting selling expense and impairment of intangible asset |  |  |  |  |  |  |  |  |  |  |  |  | $ 20,471 |  | $ 15,591 |  | $ 11,837
Reconciling items (1) |  |  |  |  |  |  |  |  |  |  |  |  |  | [1] |  | [1] |
Earnings before income taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Instruments [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  |  |  |  | $ 35,692 |  | $ 33,054 |  | $ 26,389
Gross profit |  |  |  |  |  |  |  |  |  |  |  |  | 23,223 |  | 20,763 |  | 16,904
Selling expenses |  |  |  |  |  |  |  |  |  |  |  |  | 3,848 |  | 3,441 |  | 3,954
Gross profit after deducting selling expense and impairment of intangible asset |  |  |  |  |  |  |  |  |  |  |  |  | $ 19,375 |  | $ 17,322 |  | $ 12,950
Reconciling items (1) |  |  |  |  |  |  |  |  |  |  |  |  |  | [1] |  | [1] |
Earnings before income taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Continuous Monitoring [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  |  |  |  | $ 10,792 |  | $ 10,886 |  | $ 3,343
Gross profit |  |  |  |  |  |  |  |  |  |  |  |  | 4,154 |  | 5,487 |  | 1,597
Selling expenses |  |  |  |  |  |  |  |  |  |  |  |  | 1,642 |  | 2,184 |  | 815
Gross profit after deducting selling expense and impairment of intangible asset |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,512 |  | $ 3,303 |  | $ 782
Reconciling items (1) |  |  |  |  |  |  |  |  |  |  |  |  |  | [1] |  | [1] |
Earnings before income taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cold Chain [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  |  |  |  | $ 4,526 |  |  |  |
Gross profit |  |  |  |  |  |  |  |  |  |  |  |  | 1,831 |  |  |  |
Selling expenses |  |  |  |  |  |  |  |  |  |  |  |  | 276 |  |  |  |
Gross profit after deducting selling expense and impairment of intangible asset |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,555 |  |  |  |
Reconciling items (1) |  |  |  |  |  |  |  |  |  |  |  |  |  | [1] |  | [1] |
Earnings before income taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues | $ 24,812 | $ 19,913 | $ 21,776 | $ 18,158 | $ 18,560 | $ 17,830 | $ 18,540 | $ 16,400 | $ 15,714 | $ 13,116 | $ 12,676 | $ 11,218 | $ 84,659 |  | $ 71,330 |  | $ 52,724
Gross profit | $ 14,996 | $ 12,209 | $ 13,067 | $ 11,141 | $ 11,512 | $ 11,052 | $ 11,123 | $ 9,705 | $ 9,585 | $ 7,706 | $ 7,600 | $ 6,797 | 51,413 |  | 43,392 |  | 31,688
Selling expenses |  |  |  |  |  |  |  |  |  |  |  |  | 7,500 |  | 7,176 |  | 6,119
Gross profit after deducting selling expense and impairment of intangible asset |  |  |  |  |  |  |  |  |  |  |  |  | 43,913 |  | 36,216 |  | 25,569
Reconciling items (1) |  |  |  |  |  |  |  |  |  |  |  |  | (28,358) | [1] | (20,869) | [1] | (12,466)
Earnings before income taxes |  |  |  |  |  |  |  |  |  |  |  |  | $ 15,555 |  | $ 15,347 |  | $ 13,103
[1] | Reconciling items include general and administrative, research and development, and other expenses.

X
- Definition General and administrative, research and development, and other expenses which comprise the reconciling items of reportable segment earnings before tax to the entity's consolidated earnings before tax. + References No definition available. + Details
Name: | mlab_GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
Namespace Prefix: | mlab_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the amount of gross profit after deducting selling expenses and impairment of intangible asset for the period. + References No definition available. + Details
Name: | mlab_GrossProfitAfterDeductingSellingExpenseAndImpairmentOfIntangibleAsset
Namespace Prefix: | mlab_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_GrossProfit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)(1)(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_SalesRevenueNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Expenses recognized in the period that are directly related to the selling and distribution of products or services. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_SellingExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=mlab_BiologicalIndicatorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=mlab_InstrumentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=mlab_ContinuousMonitoringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=mlab_ColdChainMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |